Exclusive

Publication

Byline

Location

Clinical Trial: Relationship Between Physiological Mirror Activity and Corticomuscular Coherence During a Finger Dexterity Task Among Healthy Young and Older Adults (Japan)

Tokyo, Sept. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063016) titled 'Relationship Between Physiological Mirror Activity and Corticomuscular Coh... Read More


Clinical Trial: The Relationship Between Temporal and Spatial Estimation Errors and the Disconnection of White Matter in Patients with Chronic Stroke (Japan)

Tokyo, Sept. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063015) titled 'The Relationship Between Temporal and Spatial Estimation Errors and the Di... Read More


Clinical Trial: Effects of Brief Postprandial Exercise Involving Large Lower-Limb Muscle Groups on Postprandial Blood Glucose Dynamics: A Crossover Study (Japan)

Tokyo, Sept. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063009) titled 'Effects of Brief Postprandial Exercise Involving Large Lower-Limb Muscle G... Read More


Clinical Trial: Evaluation of the efficacy of 8-week continuous intake of the study food on immune function - A randomized, placebo-controlled, double-blind, parallel-group study - (Japan)

Tokyo, Sept. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062965) titled 'Evaluation of the efficacy of 8-week continuous intake of the study food o... Read More


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating... Read More


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating... Read More


Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pl... Read More


Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solu... Read More


Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib ... Read More


Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pemb... Read More